Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration

  1. Owen J. Sansom1,
  2. Karen R. Reed1,
  3. Anthony J. Hayes1,
  4. Heather Ireland2,
  5. Hannah Brinkmann1,
  6. Ian P. Newton3,
  7. Eduard Batlle4,
  8. Patricia Simon-Assmann5,
  9. Hans Clevers4,
  10. Inke S. Nathke3,
  11. Alan R. Clarke1,6, and
  12. Douglas J. Winton2
  1. 1School of Biosciences, University of Cardiff, Cardiff CF10 3US, Wales; 2Cancer Research UK Department of Oncology, Cambridge CB2 2XY, UK; 3School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland; 4Hubrecht Laboratory, 3584 CT Utrecht, The Netherlands; 5INSERM U381, Strasbourg, France.

Abstract

Although Apc is well characterized as a tumor-suppressor gene in the intestine, the precise mechanism of this suppression remains to be defined. Using a novel inducible Ahcre transgenic line in conjunction with a loxP-flanked Apc allele we, show that loss of Apc acutely activates Wnt signaling through the nuclear accumulation of β-catenin. Coincidentally, it perturbs differentiation, migration, proliferation, and apoptosis, such that Apc-deficient cells maintain a “crypt progenitor-like” phenotype. Critically, for the first time we confirm a series of Wnt target molecules in an in vivo setting and also identify a series of new candidate targets within the same setting.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.287404.

  • 6 Corresponding author. E-MAIL clarkear{at}cf.ac.uk; FAX 44-0-2920-874116.

    • Accepted April 19, 2004.
    • Received October 3, 2003.
| Table of Contents

Life Science Alliance